spacer
spacer
Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Immune system PDB id
1dqt
Jmol
Contents
Protein chains
117 a.a. *
Ligands
EDO
Metals
_CL ×4
Waters ×432
* Residue conservation analysis
PDB id:
1dqt
Name: Immune system
Title: The crystal structure of murine ctla4 (cd152)
Structure: Cytotoxic t lymphocyte associated antigen 4. Chain: a, b, c, d. Fragment: extracellular fragment. Synonym: ctla4. Engineered: yes
Source: Mus musculus. House mouse. Organism_taxid: 10090. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Dimer (from PQS)
Resolution:
2.00Å     R-factor:   0.211     R-free:   0.254
Authors: D.A.Ostrov,W.Shi,J.C.Schwartz,S.C.Almo,S.G.Nathenson
Key ref:
D.A.Ostrov et al. (2000). Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science, 290, 816-819. PubMed id: 11052947 DOI: 10.1126/science.290.5492.816
Date:
05-Jan-00     Release date:   27-Oct-00    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P09793  (CTLA4_MOUSE) -  Cytotoxic T-lymphocyte protein 4
Seq:
Struc:
223 a.a.
117 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     membrane   1 term 
  Biological process     immune response   1 term 

 

 
DOI no: 10.1126/science.290.5492.816 Science 290:816-819 (2000)
PubMed id: 11052947  
 
 
Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
D.A.Ostrov, W.Shi, J.C.Schwartz, S.C.Almo, S.G.Nathenson.
 
  ABSTRACT  
 
The effective regulation of T cell responses is dependent on opposing signals transmitted through two related cell-surface receptors, CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). Dimerization of CTLA-4 is required for the formation of high-avidity complexes with B7 ligands and for transmission of signals that attenuate T cell activation. We determined the crystal structure of the extracellular portion of CTLA-4 to 2.0 angstrom resolution. CTLA-4 belongs to the immunoglobulin superfamily and displays a strand topology similar to Valpha domains, with an unusual mode of dimerization that places the B7 binding sites distal to the dimerization interface. This organization allows each CTLA-4 dimer to bind two bivalent B7 molecules and suggests that a periodic arrangement of these components within the immunological synapse may contribute to the regulation of T cell responsiveness.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Structure of CTLA-4. (A) On the right, ribbon diagram of the CTLA-4 monomer. The strands are labeled: A (3 to 6), A' (7 to 11), B (16 to 24), C (30 to 39), C' (43 to 53), C" (56 to 59), D (65 to 70), E (74 to 80), F (87 to 99), and G (103 to 114). The A'GFCC' (front) and ABEDC" (back) sheets are shown in gold and blue, respectively. Intersheet disulfide bonds between the B and F strands and between the C' and D strands are shown in yellow. Inset on the top left shows the strand topology for typical v-type immunoglobulin domains (e.g., V[H], V[L], V ). Inset on the bottom left shows the strand topology for V domains and CTLA-4 in which the C" strand is part of the back sheet. (B) Ribbon diagram of the CTLA-4 dimer. The CTLA-4 homodimer is oriented with the molecular diad axis situated vertically in the plane of the page. In this orientation, the COOH-termini extend from the bottom of the molecule. The dimer interface is formed primarily by the ABEDC" (back) sheets, shown in blue. The CDR analogous regions, CDR1 (BC loop), CDR2 (C'C" loop), and CDR3 (FG loop), form the top surface of the molecule. The distance between the CDR3 analogous regions in the dimer is 47 Å. (C) Detailed view of the CTLA-4 dimer interface. The twofold axis of the dimer is perpendicular to the page. The backbones of the CTLA-4 monomers are shown in green and in sky blue. The side chains involved in hydrogen bonding and van der Waals interactions at the dimer interface are displayed (23), with C, O, and N atoms depicted in yellow, red, and blue, respectively. Figure 1 was made with the program SETOR (41).
Figure 3.
Fig. 3. B7 binding sites on CTLA-4 and placement of CDR3 regions in dimers of immunoglobulin domains. The molecular surfaces of the TCR V V heterodimer (1tcr) and the CTLA-4 homodimer (1dqt) are shown in (A) and (B), respectively, with the CTLA-4 twofold axis oriented perpendicular to the page. Because of front-to-front packing in the TCR, the CDR3 regions shown in red are juxtaposed at the dimer interface (A), whereas the back-to-back packing present in CTLA-4 positions the CDR3 regions distal to the dimer interface (B). The two B7 binding sites on the CTLA-4 homodimer, as mapped by mutagenesis (26), include the FG loop (CDR3) shown in red, the BC loop (CDR1) shown in yellow, and solvent-accessible residues on the A'GFCC' sheet (Glu31, Arg33, Glu46, Lys93, Glu95, Phe^103, and Val104), shown in yellow (18). In contrast to V V and Fab, which are monovalent for their respective ligands (i.e., peptide-MHC complex and antigen), the placement of ligand binding sites at the extremes of the CTLA-4 dimer suggests that each CTLA-4 monomer may interact with an individual B7 dimer. (A) and (B) were prepared with GRASP (45). (C) Model of organized interactions between CTLA-4 and B7 dimers in the immunological synapse. CTLA-4 dimers, shown in red, are depicted with their COOH-termini modeled to include the disulfide bond at Cys120 near the T cell plasma membrane. CTLA-4 was manually docked to B7-1 d1, shown in light blue, to maximize the interaction between residues implicated by site-directed mutagenesis, in particular, CDR3 (Met97TyrProProProTyr102) of CTLA-4, and a hydrophobic patch on the A'GFCC'C" face of B7-1 (25). Each CTLA-4 dimer is depicted as binding two independent B7 dimers with an intermolecular spacing of approximately 77 Å and an intermembrane distance spanned by the CTLA-4-B7 ligand pair of approximately 100 Å. (C) was made with the program SETOR (41).
 
  The above figures are reprinted by permission from the AAAs: Science (2000, 290, 816-819) copyright 2000.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20394753 A.F.Sonnen, C.Yu, E.J.Evans, D.I.Stuart, S.J.Davis, and R.J.Gilbert (2010).
Domain metastability: a molecular basis for immunoglobulin deposition?
  J Mol Biol, 399, 207-213.
PDB code: 2x44
20696394 S.Radaev, Z.Zou, P.Tolar, K.Nguyen, A.Nguyen, P.D.Krueger, N.Stutzman, S.Pierce, and P.D.Sun (2010).
Structural and functional studies of Igalphabeta and its assembly with the B cell antigen receptor.
  Structure, 18, 934-943.
PDB codes: 3kg5 3kho 3khq
20037585 W.Ise, M.Kohyama, K.M.Nutsch, H.M.Lee, A.Suri, E.R.Unanue, T.L.Murphy, and K.M.Murphy (2010).
CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms.
  Nat Immunol, 11, 129-135.  
19416843 D.Schönfeld, G.Matschiner, L.Chatwell, S.Trentmann, H.Gille, M.Hülsmeyer, N.Brown, P.M.Kaye, S.Schlehuber, A.M.Hohlbaum, and A.Skerra (2009).
An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies.
  Proc Natl Acad Sci U S A, 106, 8198-8203.  
19337711 G.Dultz, M.Dittmar, and G.J.Kahaly (2009).
[Genetics of thyroid autoimmunity - update and clinical relevance.]
  Med Klin (Munich), 104, 210-219.  
19956097 H.Q.Qu, J.P.Bradfield, S.F.Grant, H.Hakonarson, and C.Polychronakos (2009).
Remapping the type I diabetes association of the CTLA4 locus.
  Genes Immun, 10, S27-S32.  
19426233 K.Chattopadhyay, E.Lazar-Molnar, Q.Yan, R.Rubinstein, C.Zhan, V.Vigdorovich, U.A.Ramagopal, J.Bonanno, S.G.Nathenson, and S.C.Almo (2009).
Sequence, structure, function, immunity: structural genomics of costimulation.
  Immunol Rev, 229, 356-386.  
19188497 R.H.Friedline, D.S.Brown, H.Nguyen, H.Kornfeld, J.Lee, Y.Zhang, M.Appleby, S.D.Der, J.Kang, and C.A.Chambers (2009).
CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.
  J Exp Med, 206, 421-434.  
19426215 T.Pentcheva-Hoang, E.Corse, and J.P.Allison (2009).
Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.
  Immunol Rev, 229, 67-87.  
18641123 E.Lázár-Molnár, Q.Yan, E.Cao, U.Ramagopal, S.G.Nathenson, and S.C.Almo (2008).
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2.
  Proc Natl Acad Sci U S A, 105, 10483-10488.
PDB codes: 3bov 3bp5
  18832683 G.Kim, O.Turovskaya, M.Levin, F.R.Byrne, J.S.Whoriskey, J.G.McCabe, and M.Kronenberg (2008).
Spontaneous colitis occurrence in transgenic mice with altered B7-mediated costimulation.
  J Immunol, 181, 5278-5288.  
18186109 R.Eri, K.N.Kodumudi, D.J.Summerlin, and M.Srinivasan (2008).
Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease.
  Inflamm Bowel Dis, 14, 458-470.  
20477681 B.S.Clay, and A.I.Sperling (2007).
T-cell costimulation blockade in immunologic diseases: role of CD28 family members.
  Expert Rev Clin Immunol, 3, 383-393.  
17667521 M.B.Atkins, D.Carbone, G.Coukos, M.Dhodapkar, M.S.Ernstoff, J.Finke, T.F.Gajewski, J.Gollob, M.T.Lotze, W.Storkus, and L.M.Weiner (2007).
Report on the ISBTC mini-symposium on biologic effects of targeted therapeutics.
  J Immunother (1997), 30, 577-590.  
17624952 P.Reichardt, B.Dornbach, and M.Gunzer (2007).
The molecular makeup and function of regulatory and effector synapses.
  Immunol Rev, 218, 165-177.  
16405652 A.J.Hueber, F.G.Matzkies, M.Rahmeh, B.Manger, J.R.Kalden, and T.Nagel (2006).
CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas.
  Immunol Cell Biol, 84, 51-58.  
16799561 J.A.Hernández Prada, R.N.Haire, M.Allaire, J.Jakoncic, V.Stojanoff, J.P.Cannon, G.W.Litman, and D.A.Ostrov (2006).
Ancient evolutionary origin of diversified variable regions demonstrated by crystal structures of an immune-type receptor in amphioxus.
  Nat Immunol, 7, 875-882.
PDB codes: 1xt5 2fbo
16551244 W.A.Teft, M.G.Kirchhof, and J.Madrenas (2006).
A molecular perspective of CTLA-4 function.
  Annu Rev Immunol, 24, 65-97.  
  15762980 D.A.Chistiakov (2005).
Immunogenetics of Hashimoto's thyroiditis.
  J Autoimmune Dis, 2, 1.  
15696168 E.J.Evans, R.M.Esnouf, R.Manso-Sancho, R.J.Gilbert, J.R.James, C.Yu, J.A.Fennelly, C.Vowles, T.Hanke, B.Walse, T.Hünig, P.Sørensen, D.I.Stuart, and S.J.Davis (2005).
Crystal structure of a soluble CD28-Fab complex.
  Nat Immunol, 6, 271-279.
PDB code: 1yjd
16227150 T.Okazaki, and J.Wang (2005).
PD-1/PD-L pathway and autoimmunity.
  Autoimmunity, 38, 353-357.  
15357951 T.Pentcheva-Hoang, J.G.Egen, K.Wojnoonski, and J.P.Allison (2004).
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
  Immunity, 21, 401-413.  
15030777 X.Zhang, J.C.Schwartz, X.Guo, S.Bhatia, E.Cao, M.Lorenz, M.Cammer, L.Chen, Z.Y.Zhang, M.A.Edidin, S.G.Nathenson, and S.C.Almo (2004).
Structural and functional analysis of the costimulatory receptor programmed death-1.
  Immunity, 20, 337-347.
PDB code: 1npu
12697893 A.E.Prota, J.A.Campbell, P.Schelling, J.C.Forrest, M.J.Watson, T.R.Peters, M.Aurrand-Lions, B.A.Imhof, T.S.Dermody, and T.Stehle (2003).
Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding.
  Proc Natl Acad Sci U S A, 100, 5366-5371.
PDB code: 1nbq
14512535 B.P.Nayak, G.Sailaja, and A.M.Jabbar (2003).
Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.
  J Virol, 77, 10850-10861.  
12707298 D.H.Margulies (2003).
CD28, costimulator or agonist receptor?
  J Exp Med, 197, 949-953.  
12707299 F.Lühder, Y.Huang, K.M.Dennehy, C.Guntermann, I.Müller, E.Winkler, T.Kerkau, S.Ikemizu, S.J.Davis, T.Hanke, and T.Hünig (2003).
Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists.
  J Exp Med, 197, 955-966.  
12787753 J.H.Wang, and M.J.Eck (2003).
Assembling atomic resolution views of the immunological synapse.
  Curr Opin Immunol, 15, 286-293.  
12859525 M.L.Baroja, and J.Madrenas (2003).
Viewpoint: therapeutic implications of CTLA-4 compartmentalization.
  Am J Transplant, 3, 919-926.  
12615890 P.A.van der Merwe, and S.J.Davis (2003).
Molecular interactions mediating T cell antigen recognition.
  Annu Rev Immunol, 21, 659-684.  
  14656437 S.Radaev, M.Kattah, B.Rostro, M.Colonna, and P.D.Sun (2003).
Crystal structure of the human myeloid cell activating receptor TREM-1.
  Structure, 11, 1527-1535.
PDB code: 1q8m
12719480 S.Wang, J.Bajorath, D.B.Flies, H.Dong, T.Honjo, and L.Chen (2003).
Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction.
  J Exp Med, 197, 1083-1091.  
12670402 T.Saito, and S.Yamasaki (2003).
Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors.
  Immunol Rev, 192, 143-160.  
12627395 T.Stehle, and T.S.Dermody (2003).
Structural evidence for common functions and ancestry of the reovirus and adenovirus attachment proteins.
  Rev Med Virol, 13, 123-132.  
12021313 P.J.Darlington, M.L.Baroja, T.A.Chau, E.Siu, V.Ling, B.M.Carreno, and J.Madrenas (2002).
Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation.
  J Exp Med, 195, 1337-1347.  
11973140 R.J.Greenwald, Y.E.Latchman, and A.H.Sharpe (2002).
Negative co-receptors on lymphocytes.
  Curr Opin Immunol, 14, 391-396.  
11244047 C.A.Chambers, M.S.Kuhns, J.G.Egen, and J.P.Allison (2001).
CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
  Annu Rev Immunol, 19, 565-594.  
  11274928 C.A.Chambers (2001).
The expanding world of co-stimulation: the two-signal model revisited.
  Trends Immunol, 22, 217-223.  
11905831 M.L.Alegre, K.A.Frauwirth, and C.B.Thompson (2001).
T-cell regulation by CD28 and CTLA-4.
  Nat Rev Immunol, 1, 220-228.  
11532194 S.Z.Liu, S.Z.Jin, X.D.Liu, and Y.M.Sun (2001).
Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes.
  BMC Immunol, 2, 8.  
11500393 T.K.Varma, T.E.Toliver-Kinsky, C.Y.Lin, A.P.Koutrouvelis, J.E.Nichols, and E.R.Sherwood (2001).
Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice.
  Infect Immun, 69, 5249-5263.  
11375523 X.Zhang, J.C.Schwartz, S.G.Nathenson, and S.C.Almo (2001).
Crystallization and preliminary X-ray analysis of the complex between human CTLA-4 and B7-2.
  Acta Crystallogr D Biol Crystallogr, 57, 898-899.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.